Cerus (CERS) Total Current Liabilities (2010 - 2026)
Cerus (CERS) reported Total Current Liabilities of $107.4 million for Q1 2026, up 54.09% on a YoY basis from $69.7 million in Q1 2025, and up 6.53% sequentially from $100.8 million in Q4 2025.
Cerus (CERS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Total Current Liabilities data on file, last reported at $107.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 54.09% year-over-year to $107.4 million; the trailing twelve-month figure through Mar 2026 stood at $107.4 million (up 54.09% YoY), and the FY2025 full-year result was $100.8 million, up 58.47% from the prior year.
- Total Current Liabilities climbed to $107.4 million in Q1 2026, from $100.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $117.1 million in Q4 2022 to a low of $53.9 million in Q2 2024.
- A 5-year average of $78.7 million and a median of $77.6 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 42.32% in 2023 and soared 62.73% in 2025, its largest moves.
- Tracing CERS's Total Current Liabilities over 5 years: stood at $117.1 million in 2022, then sank by 42.32% to $67.5 million in 2023, then slipped by 5.8% to $63.6 million in 2024, then soared by 58.47% to $100.8 million in 2025, then advanced by 6.53% to $107.4 million in 2026.
- Business Quant data shows CERS's Total Current Liabilities at $107.4 million in Q1 2026, $100.8 million in Q4 2025, and $88.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 107.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.38 Mn |
| Dec 31, 2025 | 100.80 Mn |
| Sep 30, 2025 | 88.43 Mn |
| Jun 30, 2025 | 84.36 Mn |
| Mar 31, 2025 | 69.69 Mn |
| Dec 31, 2024 | 63.61 Mn |
| Sep 30, 2024 | 54.35 Mn |
| Jun 30, 2024 | 53.88 Mn |
| Mar 31, 2024 | 57.25 Mn |
| Dec 31, 2023 | 67.52 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 75.08 Mn |
| Mar 31, 2023 | 77.57 Mn |
| Dec 31, 2022 | 117.06 Mn |
| Sep 30, 2022 | 95.02 Mn |
| Jun 30, 2022 | 79.28 Mn |
| Mar 31, 2022 | 66.66 Mn |
| Dec 31, 2021 | 78.56 Mn |
| Sep 30, 2021 | 64.72 Mn |
| Jun 30, 2021 | 65.82 Mn |